Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Shinsaku Tsuchimochi"'
Autor:
Yasuyuki Sagara, Tetsuaki Rai, Taeko Kukita, Yoshiaki Sagara, Shinsaku Tsuchimochi, Tetsuya Takahama, Yoshito Matsuyama, Fumiyo Yonenaga, Yasuyo Oi, Mitsutake Ando, Yoshiatsu Sagara
Publikováno v:
Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 15:221-226
Publikováno v:
American Journal of Roentgenology. 180:1649-1657
The aim of our study was to assess quantitative methods of distinguishing adenomas from malignant adrenal lesions using chemical shift fast low-angle shot MR imaging.We assessed 102 adrenal tumors in 88 patients (27 hyperfunctioning and 44 nonhyperfu
Publikováno v:
Annals of Nuclear Medicine. 14:205-212
An adrenocortical adenoma causing Cushing's syndrome (Cushing's adenoma) produces a unilateral concordant visualization (UCV) imaging pattern in which the adenoma is only visualized on radioiodocholesterol adrenocortical scintigraphy. But because thi
Autor:
Atsushi Tani, Mitsuhiro Osame, Shinsaku Tsuchimochi, Mitsuru Mitsuda, Yoshiaki Nakabeppu, Masayuki Nakajo
Publikováno v:
Annals of Nuclear Medicine. 13:447-452
I-123 IBF is a dopaminergic antagonist which is suitable for SPECT imaging of D2 receptors. The purpose of this study is to evaluate the potential usefulness of semi-quantitative parameters obtained from brain SPECT data of I-123 IBF for differential
Publikováno v:
CLINICAL NUCLEAR MEDICINE. 22:687-690
Pulmonary metastases from malignant pheochromocytoma were seen with I-123 MIBG SPECT in a 16-year-old girl but were not visualized with I-123 MIBG planar imaging. She had a left adrenalectomy for a pheochromocytoma 7 years earlier. Two small pulmonar
Autor:
Shinsaku Tsuchimochi, Hiroaki Tanabe, Megumi Jinguji, Yoshiaki Nakabeppu, Tomoichi Umanodan, Masayuki Nakajo
Publikováno v:
Annals of nuclear medicine. 21(8)
The purpose of this study was to retrospectively examine the correlations of hormonal ratios with radioiodine I-131 therapeutic parameters and the potentiality of prescribing the therapeutic I-131 target dosage for an individual patient with Graves'
Publikováno v:
Annals of Nuclear Medicine. 11:321-323
Bone scintigraphy was performed in a 69-year-old male patient with adult T-cell leukemia suffering from right lower limb pain. Numerous sites of increased uptake were seen in the skull, left clavicle, bilateral humeri, bilateral radii and right femur
Publikováno v:
Annals of nuclear medicine. 19(4)
The purpose of this study was to clarify the characteristic patterns of the thyroid hormonal changes in Graves' disease during the one-year period after 131I therapy considering that few serial hormonal data during this period are available in the li
Autor:
Yoriko, Kajiya, Kiyohisa, Kamimura, Megumi, Jinguji, Masayuki, Nakajo, Shinsaku, Tsuchimochi, Katsumi, Sako, Yasuji, Komorizono
Publikováno v:
Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica. 65(2)
To investigate the appropriate time of arterial phase for the detection of hypervascular hepatocellular carcinoma (HCC).Fifty-two hypervascular HCCs of 36 patients were evaluated on double arterial-phase images of the liver. The first and second arte
Autor:
Yutaka, Mori, Kiyoko, Kusakabe, Katsuji, Ikekubo, Naofumi, Ishikawa, Kunihiro, Nakada, Shinichi, Kanaya, Takashi, Misaki, Kunihiko, Yokoyama, Atsushi, Kubo, Tatsuya, Higashi, Kouichi, Itou, Yasushi, Noguchi, Shinsaku, Tsuchimochi, Takashi, Togawa
Publikováno v:
Kaku igaku. The Japanese journal of nuclear medicine. 42(1)
Radio-iodine (131I) therapy has been using in Graves' disease and well differentiated thyroid cancer. The rules of control in the discharge from radio-isotope hospital were notified in 1999 in Japan. Guideline of the 131I therapy in Graves' disease a